Controlar robots con la mente, las plantas emiten ultrasonidos, astronautas que sobrevolarán la Luna
Noticias de la actualidad científica y tecnológica del 14 de abril de 2023. …
Noticias de la actualidad científica y tecnológica del 14 de abril de 2023. …
Hay un agujero negro que, pese a su enorme masa de 20 millones de veces la de nuestro Sol, avanza por el espacio intergaláctico muchísimo más rápido que la más veloz de nuestras naves espaciales. A esa velocidad, este astro tan masivo podría viajar de la Tie …
Agujero negro errante con una cola de estrellas detrás Read More »
Nuvalent, Inc. announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the Stifel 2023 Virtual Targeted Oncology Days on Wednesday, April 26, 2023, at 1:30 p.m. ET.
Nuvalent to Participate in the Stifel 2023 Virtual Targeted Oncology Days Read More »
AlzeCure Pharma AB announced that an abstract on ACD440, the leading non-opioid drug candidate in the Painless platform, has been accepted for presentation at the annual international pain conference EFIC, European Pain Federation, which this year is being held in Budapest, Hungary, on September 20-22.
Lytix Biopharma AS, a clinical stage immuno-oncology company, announces the election of a new Chairman of the Board at ‘s General Assembly.
Lytix Biopharma appoints new Chairman of the Board – April 19, 2023 Read More »
BioArctic AB will publish the company’s first quarter report for January – March 2023 on Thursday, April 27, 2023, at 08:00 a.m. CET.
The American Lung Association’s new “State of the Air” report finds that nearly 120 million people in the U.S., or more than one in three, live in counties that had unhealthy levels of ozone or particle pollution.
Nona Biosciences announced it has entered into a collaboration agreement with Michael S. Diamond, MD, PhD, of Washington University in St. Louis to discover viral targets for which few or no human monoclonal antibodies currently exist, such as western equine encephalitis virus, rabies and severe fever with thrombocytopenia syndrome virus.
Nona Biosciences and Washington University Join Forces to Tackle Emerging RNA Viruses Read More »
ImmVira presented preclinical study results of CAR-T enabler oHSV product MVR-7011 through poster publication at the American Association for Cancer Research annual meeting.
Modalis Therapeutics Corporation announced that the abstract has been accepted for a presentation in the late-breaking session at the 26th Annual Meeting of The American Society of Gene & Cell Therapy, being held in Los Angeles CA on May 16-20, 2023.